Concentration of the drug ustekinumab in the blood four weeks after injection, is linked to how well moderate‐to‐severe psoriasis responds to treatment

Authors :: E. De Keyser
Jo Lambert
N Van den Berghe
Ann Gils
Rani Soenen
Sven Lanssens
L. Meuleman
Source :: British Journal of Dermatology. 182
Publication Year :: 2020
Publisher :: Oxford University Press (OUP), 2020.

Subjects :: Drug
medicine.medical_specialty
business.industry
media_common.quotation_subject
Moderate to severe psoriasis
Ustekinumab
Medicine
Dermatology
business
media_common
medicine.drug

Full Text Access

Tools